Literature DB >> 18952578

Childhood brain tumors: accomplishments and ongoing challenges.

Roger J Packer1.   

Abstract

The management of childhood brain tumors, which consist of many different histological subtypes, continues to be a challenge. Outcome, measured not only by survival rates but also by the effects of disease and therapy on quality of life, has improved over the past two decades for some tumor types, most notably medulloblastomas. For others, however, there has been little progress, and quality of life for long-term survivors remains suboptimal. Because of advances in our understanding of the biology underlying childhood brain tumors, treatments may change dramatically in the years ahead. Accordingly, survival rates may improve and long-term sequelae lessen.

Entities:  

Mesh:

Year:  2008        PMID: 18952578      PMCID: PMC3674838          DOI: 10.1177/0883073808320758

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  41 in total

1.  Prediction of central nervous system embryonal tumour outcome based on gene expression.

Authors:  Scott L Pomeroy; Pablo Tamayo; Michelle Gaasenbeek; Lisa M Sturla; Michael Angelo; Margaret E McLaughlin; John Y H Kim; Liliana C Goumnerova; Peter M Black; Ching Lau; Jeffrey C Allen; David Zagzag; James M Olson; Tom Curran; Cynthia Wetmore; Jaclyn A Biegel; Tomaso Poggio; Shayan Mukherjee; Ryan Rifkin; Andrea Califano; Gustavo Stolovitzky; David N Louis; Jill P Mesirov; Eric S Lander; Todd R Golub
Journal:  Nature       Date:  2002-01-24       Impact factor: 49.962

2.  Influence of tumor grade on time to progression after irradiation for localized ependymoma in children.

Authors:  Thomas E Merchant; Jesse J Jenkins; Peter C Burger; Robert A Sanford; Scot H Sherwood; Dana Jones-Wallace; Richard L Heideman; Stephen J Thompson; Kathleen J Helton; Larry E Kun
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-05-01       Impact factor: 7.038

3.  Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children's Oncology Group.

Authors:  Patricia L Robertson; Karin M Muraszko; Emiko J Holmes; Richard Sposto; Roger J Packer; Amar Gajjar; Mark S Dias; Jeffrey C Allen
Journal:  J Neurosurg       Date:  2006-12       Impact factor: 5.115

4.  Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease.

Authors:  T J MacDonald; K M Brown; B LaFleur; K Peterson; C Lawlor; Y Chen; R J Packer; P Cogen; D A Stephan
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

5.  Expression of p53 and prognosis in children with malignant gliomas.

Authors:  Ian F Pollack; Sydney D Finkelstein; Jeffrey Woods; Judith Burnham; Emiko J Holmes; Ronald L Hamilton; Allan J Yates; James M Boyett; Jonathan L Finlay; Richard Sposto
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245

6.  Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop.

Authors:  Roger J Packer; Jaclyn A Biegel; Susan Blaney; Jonathan Finlay; J Russell Geyer; Richard Heideman; Joanne Hilden; Anna J Janss; Larry Kun; Gilbert Vezina; Lucy B Rorke; Malcolm Smith
Journal:  J Pediatr Hematol Oncol       Date:  2002 Jun-Jul       Impact factor: 1.289

7.  Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study.

Authors:  Roger E Taylor; Clifford C Bailey; Kath Robinson; Claire L Weston; David Ellison; James Ironside; Helen Lucraft; Richard Gilbertson; Diana M Tait; David A Walker; Barry L Pizer; John Imeson; Linda S Lashford
Journal:  J Clin Oncol       Date:  2003-04-15       Impact factor: 44.544

8.  Clinical and molecular stratification of disease risk in medulloblastoma.

Authors:  R Gilbertson; C Wickramasinghe; R Hernan; V Balaji; D Hunt; D Jones-Wallace; J Crolla; R Perry; J Lunec; A Pearson; D Ellison
Journal:  Br J Cancer       Date:  2001-09-01       Impact factor: 7.640

9.  Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study.

Authors:  James G Gurney; Nina S Kadan-Lottick; Roger J Packer; Joseph P Neglia; Charles A Sklar; Judy A Punyko; Marilyn Stovall; Yutaka Yasui; H Stacy Nicholson; Suzanne Wolden; Dawn E McNeil; Ann C Mertens; Leslie L Robison
Journal:  Cancer       Date:  2003-02-01       Impact factor: 6.921

10.  Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study.

Authors:  Roger J Packer; James G Gurney; Judy A Punyko; Sarah S Donaldson; Peter D Inskip; Marilyn Stovall; Yutaka Yasui; Ann C Mertens; Charles A Sklar; H Stacy Nicholson; Lonnie K Zeltzer; Joseph P Neglia; Leslie L Robison
Journal:  J Clin Oncol       Date:  2003-09-01       Impact factor: 50.717

View more
  29 in total

Review 1.  Pediatric brain tumor treatment: growth consequences and their management.

Authors:  Sogol Mostoufi-Moab; Adda Grimberg
Journal:  Pediatr Endocrinol Rev       Date:  2010-09

Review 2.  Use of T2 signal intensity of cerebellar neoplasms in pediatric patients to guide preoperative staging of the neuraxis.

Authors:  Jonathan A Forbes; Lola B Chambless; Jason G Smith; Curtis A Wushensky; Richard L Lebow; JoAnn Alvarez; Matthew M Pearson
Journal:  J Neurosurg Pediatr       Date:  2011-02       Impact factor: 2.375

3.  Harvey Cushing's early experience with pediatric gliomas.

Authors:  Neda I Sedora-Román; Courtney Pendleton; Ahmed Mohyeldin; Alfredo Quiñones-Hinojosa
Journal:  Childs Nerv Syst       Date:  2011-02-02       Impact factor: 1.475

Review 4.  Neuropsychological sequelae and quality of life following treatment of posterior fossa ependymomas in children.

Authors:  Constantinos Charalambides; Argyris Dinopoulos; Spyros Sgouros
Journal:  Childs Nerv Syst       Date:  2009-06-25       Impact factor: 1.475

Review 5.  Consensus paper on post-operative pediatric cerebellar mutism syndrome: the Iceland Delphi results.

Authors:  Thora Gudrunardottir; Angela T Morgan; Andrew L Lux; David A Walker; Karin S Walsh; Elizabeth M Wells; Jeffrey H Wisoff; Marianne Juhler; Jeremy D Schmahmann; Robert F Keating; Coriene Catsman-Berrevoets
Journal:  Childs Nerv Syst       Date:  2016-05-03       Impact factor: 1.475

Review 6.  Social competence in childhood brain tumor survivors: a comprehensive review.

Authors:  Fiona Schulte; Maru Barrera
Journal:  Support Care Cancer       Date:  2010-08-01       Impact factor: 3.603

7.  Findings on preoperative brain MRI predict histopathology in children with cerebellar neoplasms.

Authors:  Jonathan A Forbes; Adam S Reig; Jason G Smith; Walter Jermakowicz; Luke Tomycz; Sheila D Shay; David A Sun; Curtis A Wushensky; Matthew M Pearson
Journal:  Pediatr Neurosurg       Date:  2011-08-22       Impact factor: 1.162

8.  Establishment and characterization of clinically relevant models of ependymoma: a true challenge for targeted therapy.

Authors:  Su Guan; Ruijun Shen; Tiffany Lafortune; Ningyi Tiao; Peter Houghton; W K Alfred Yung; Dimpy Koul
Journal:  Neuro Oncol       Date:  2011-06-08       Impact factor: 12.300

9.  miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma.

Authors:  Shyamal D Weeraratne; Vladimir Amani; Adrianne Neiss; Natalia Teider; Deborah K Scott; Scott L Pomeroy; Yoon-Jae Cho
Journal:  Neuro Oncol       Date:  2010-12-22       Impact factor: 12.300

10.  Lack of prognostic significance of survivin in pediatric medulloblastoma.

Authors:  Roberta Soares Faccion; Regina Moreira Ferreira; Marília Fornaciari Grabois; Theresinha Carvalho Fonseca; Jose Antonio de Oliveira; Raquel Ciuvalschi Maia
Journal:  Pathol Oncol Res       Date:  2011-06-17       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.